Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
JAMA|June 14, 2024
Germline CDH1 Variants and Lifetime Cancer RiskCarrie E Ryan, Grace-Ann Fasaye, Amber F Gallanis, et al.Annals of Surgical Oncology|January 4, 2020
Correction to: Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric CancerElke J A H van Beek, Jonathan M Hernandez, Debra A Goldman, et al.Annals of Surgical Oncology|May 5, 2018
Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric CancerElke J A H van Beek, Jonathan M Hernandez, Debra A Goldman, et al.Annals of Surgical Oncology|January 16, 2026
Efficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical TrialsAmber F Gallanis, Shruthi R Perati, Stephanie N Canady, et al.Molecular Cancer Research : MCR|April 7, 2025
Spatial analysis of hereditary diffuse gastric cancer reveals indolent phenotype of signet ring cell precursorsAmber F Gallanis, Lauren A Gamble, Cihan Oguz, et al.Cancer Prevention Research (Philadelphia, Pa.)|April 26, 2024
Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric CancerChi-Lee C Ho, Michael B Gilbert, Guillaume Urtecho, et al.Cell Reports|November 19, 2023
Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencingAmanda J Craig, Maruhen A Datsch Silveira, Lichun Ma, et al.Journal of Medical Genetics|January 5, 2023
Optimising clinical care through <i>CDH1</i>-specific germline variant curation: improvement of clinical assertions and updated curation guidelinesXi Luo, Jamie L Maciaszek, Bryony A Thompson, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitisMaria R Parkhurst, James C Yang, Russell C Langan, et al.Journal of Hepatology|November 7, 2016
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G Duffy, Susanna V Ulahannan, Oxana Makorova-Rusher, et al.Pageof 13